Abnormal bolus reflux on impedance-pH testing independently predicts 3-year pulmonary outcome and mortality in pulmonary fibrosis.
Mariel E BaileyLawrence F BorgesHilary J GoldbergKelly E HathornSravanya GaviniWai-Kit LoWalter Wai-Yip ChanPublished in: Journal of gastroenterology and hepatology (2023)
Increased BET on MII-pH is an independent predictor of poor pulmonary outcomes and mortality over 3 years in IPF patients. These findings also support a role for gastroesophageal reflux in IPF disease progression and the potential impact of routine reflux testing and treatment.
Keyphrases
- pulmonary fibrosis
- end stage renal disease
- pulmonary hypertension
- idiopathic pulmonary fibrosis
- cardiovascular events
- newly diagnosed
- ejection fraction
- chronic kidney disease
- risk factors
- prognostic factors
- peritoneal dialysis
- type diabetes
- computed tomography
- cardiovascular disease
- magnetic resonance imaging
- coronary artery disease
- magnetic resonance
- patient reported outcomes
- metabolic syndrome
- adipose tissue